An interventional study of Transcutaneous Laryngeal Ultrasonography in Recurrent Laryngeal Nerve Palsy and Postoperative Dysphonia, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 5 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-07.
Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Diagnostic
One of the major risks of endocrine surgery is recurrent nerve palsy (RNP), leading to vocal folds (VF) immobility. It happens in 5% of cases, leading to high morbidity: dysphonia, aspirations, impossibility to work. Guidelines recommend to systematically perform a nasofibroscopy before and after surgery to check vocal fold mobility. However, due to the decreasing number of specialists, the cost of decontamination, and discomfort of this procedure, these guidelines are insufficiently followed.
Transcutaneous Laryngeal Ultrasonography (TLU) appears a good alternative to nasofibroscopy in evaluating VF mobility, as assessed by the recent flourishing literature. Our team is a leader in this research by having developed a dedicated software, which provides objective measures of VF mobility. The aim of the present protocol is to validate the power of TLU for the diagnosis of RNP on a large cohort of patients operated on endocrine surgery. It is a prospective multicentric study that will blindly compare TLU and nasofibroscopy, the latter being the gold standard. TLU is cost effective and painless; its learning curve is fast. If validated, it may be offered as a good alternative to nasofibroscopy in RNP detection and prognosis.
The rationale of this study is that Transcutaneous Laryngeal Ultrasonography (TLU) may be a relevant and reliable tool in assessing vocal folds (VF) paralysis secondary to endocrine surgery (thyroid and parathyroid surgery). According to the literature and to our own publications, subjective impression of VF (im)mobility seems sufficient to diagnose a paralysis. However, the investigators think that objective measures, based on a dedicated semi-automatic software, may offer a much powerful implement and needs to be compared to the gold standard technique, i.e. the nasofibroscopy (NF), in a large prospective multicentric cohort.
In a preliminary study, the investigators described TLU anatomical landmarks first in an ex vivo study and secondary in a prospective study based on 50 patients with VF paralysis compared to 50 controls. These three landmarks, the two arytenoids and the anterior insertion of the two vocal folds on the thyroid cartilage, are easy to recognize, and independent of the postoperative delay and the person performing TLU. They define two symmetrical hemi-larynges in healthy subjects. The investigators designed an original software, aiming at offering two quantitative criteria of laryngeal mobility and symmetry, taking into account motion symmetry (symmetry index) and amplitude (mobility index) of the two hemi-larynges. When a subject presented with a unilateral VF paralysis, the mean symmetry index was significantly larger compared to the control group (20.4% ±13.8% versus 6.7% ±4.7%, p\<0.0001) and the mean lower mobility index was significantly smaller (2.2% ±17.4% versus 20.5% ±14.8%, p\<0.0001). The sensitivity and specificity of this first version of our automatized protocol were 82%.
The aim of the present study is to validate TLU as an alternative to NF in a large independent cohort of patients operated on endocrine surgery. The main goal is to improve the sensitivity and specificity of the objective measures and implement new parameters in the software. By a ready to use tool, the investigators would like to offer the opportunity to any practitioner to assess and quantify VF (im)mobility with their usual US machine.
The subjects will be recruited in the three different clinical centers, highly specialized in endocrine surgery. The aim of 500 subjects included seems feasible thanks to the high activity of these centers. Moreover the latter already have sufficient and qualified staff and technical tools to perform clinical follow up, US, and NF.
The technical acquisition is as follow. The TLU is performed with a 7-14 MHz linear probe, using a portable machine. Subjects are lying on the back, neck slightly extended, with the probe placed over the laryngeal prominence of the thyroid cartilage, including the arytenoids in the axial view. The images are acquired in B-mode, during normal breathing at rest. Typical values for acquisition are: frequency 10 MHz, depth of field of view 4 cm, mechanical index 0.6, gain 45%, dynamic range 85 decibels. A video clip of 10 seconds (30 images per second) is recorded in order to include 5 to 6 complete respiratory cycles. Two images corresponding to physiological abduction and adduction during the same breath cycle are selected. The landmarks, previously described, are selected on the images and tracked by the software.
All patients operated on endocrine surgery in the three referral centers and responding to the inclusion criteria will be included after obtaining their writing consent. The gold standard NF will be performed between D1 and D15, as usually performed after these surgeries. TLU will be performed during the same time period by an investigator blind to the NF results. The subject will be his own control, NF and TLU being compared. When facing VF immobility, the subject will benefit from the usual clinical follow up: consultation with NF at 6 weeks and 6 months. TLU will be added to these appointments.
61 studies on the registry are indexed under Vocal Cord Paralysis; 16 are open to participants now.
This study's planned enrollment of 500 is above the median of 39 across 43 interventional studies indexed under Vocal Cord Paralysis.
Browse Vocal Cord Paralysis studies →Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All patients operated on endocrine surgery in the three referral centers and responding to the inclusion criteria will be included after obtaining their writing consent. The gold standard NF will be performed between D1 and D15, as usually performed after these surgeries. TLU will be performed during the same time period by an investigator blind to the NF results. The subject will be his own control, NF and TLU being compared. When facing VF immobility, the subject will benefit from the usual clinical follow up: consultation with NF at 6 weeks and 6 months. TLU will be added to these appointments.
Device: Transcutaneous Laryngeal Ultrasonography
TLU will be performed during the same time period of The gold standard NF (who is performed as usually after endocrine surgeries) by an investigator blind to the NF results, between D1 and D15. The subject will be his own control, NF and TLU being compared. When facing VF immobility, the subject will benefit from the usual clinical follow up: consultation with NF at 6 weeks and 6 months. TLU will be added to these appointments.
Diagnostic performance associated with the postoperative quantitative TLU (i.e. measured by asymmetry in vocal cord mobility obtained with our dedicated software of image analysis) for the diagnostic of postoperative recurrent nerve palsy (RNP).
The diagnostic performance of the postoperative measurement of asymmetry in vocal cord mobility obtained with the quantitative TLU will be evaluated by the area under the roc curve and its 95% confidence interval. The gold standard for diagnosis of postoperative RNP will be the nasofibroscopy performed between Day 1 and Day15.
Time frame: Between Day 1(the day after the surgery) and Day 15
Diagnostic performance associated with the postoperative qualitative TLU (i.e. obtained by the operator during TLU, without the use of our dedicated software for the diagnostic of postoperative recurrent nerve palsy (RNP).
The diagnostic performance of the postoperative qualitative evaluation of asymmetry in vocal cord mobility obtained by the operator during TLU will be evaluated using sensitivity, specificity, positive and negative predictive value and and their 95% confidence interval. The gold standard for diagnosis of postoperative RNP will be the nasofibroscopy performed between Day 1 and Day 15.
Time frame: Between Day 1(the day after the surgery) and Day 15
Predictive performance associated with the postoperative quantitative TLU for the diagnosis of final recovery of RNP, among subjects with postoperative RNP.
The predictive performance of the measurement of asymmetry in vocal cord mobility obtained with the postoperative quantitative TLU will be evaluated among patients with postoperative RNP by the area under the roc curve and its 95% confidence interval. The gold standard for diagnosis of final recovery of RNP will be the nasofibroscopy performed 6 months after surgery.
Time frame: 6 months after surgery
Predictive performance associated with the postoperative qualitative TLU for the diagnosis of final recovery of RNP, among subjects with postoperative RNP.
The predictive performance of the postoperative qualitative evaluation of asymmetry in vocal cord mobility obtained by the operator during TLU will be evaluated using sensitivity, specificity, positive and negative predictive value and and their 95% confidence interval. The gold standard for diagnosis of final recovery of RNP will be the nasofibroscopy performed 6 months after surgery.
Time frame: 6 months (e.g. 6 months after surgery)
Predictive performance associated with the quantitative TLU performed 6 weeks after surgery for the diagnosis of final recovery of RNP, among subjects with postoperative RNP.
The predictive performance of the measurement of asymmetry in vocal cord mobility obtained with the quantitative TLU 6 weeks after surgery will be evaluated among patients with postoperative RNP by the area under the roc curve and its 95% confidence interval. The gold standard for diagnosis of final recovery of RNP will be the nasofibroscopy performed 6 months after surgery.
Time frame: 6 months after surgery
Predictive performance associated with the qualitative TLU performed 6 weeks after surgery for the diagnosis of final recovery of RNP, among subjects with postoperative.
The predictive performance of the qualitative evaluation of asymmetry in vocal cord mobility obtained by the operator during TLU performed 6 weeks after surgery will be evaluated using sensitivity, specificity, positive and negative predictive value and and their 95% confidence interval. The gold standard for diagnosis of final recovery of RNP will be the nasofibroscopy performed 6 months after surgery.
Time frame: 6 months after surgery
Diagnostic performance associated with the quantitative TLU performed 6 months after surgery for the diagnosis of final recovery of RNP, among subjects with postoperative RNP.
The diagnostic performance of the measurement of asymmetry in vocal cord mobility obtained with the quantitative TLU 6 months after surgery will be evaluated among patients with postoperative RNP by the area under the roc curve and its 95% confidence interval. The gold standard for diagnosis of final recovery of RNP will be the nasofibroscopy performed 6 months after surgery.
Time frame: 6 months after surgery
Diagnostic performance associated with the qualitative TLU performed 6 months after surgery for the diagnosis of final recovery of RNP, among subjects with postoperative RNP.
The diagnostic performance of the qualitative evaluation of asymmetry in vocal cord mobility obtained by the operator during TLU performed 6 months after surgery will be evaluated using sensitivity, specificity, positive and negative predictive value and and their 95% confidence interval. The gold standard for diagnosis of final recovery of RNP will be the nasofibroscopy performed 6 months after surgery.
Time frame: 6 months after surgery
Correlation between the postoperative Voice Handicap Index (VHI) and the postoperative quantitative TLU.
Pearson correlation coefficient between postoperative quantitative TLU and VHI
Time frame: Between Day 1(the day after the surgery) and Day 15
Correlation between the Voice Handicap Index (VHI) measured 6 weeks after surgery and the quantitative TLU measured 6 weeks after surgery, among subjects with postoperative RNP.
Pearson correlation coefficient between quantitative TLU and VHI at 6 weeks
Time frame: 6 weeks after surgery (+/- 15 days)
Correlation between the Voice Handicap Index (VHI) measured 6 months after surgery and the quantitative TLU measured 6 months after surgery, among subjects with postoperative RNP.
Pearson correlation coefficient between quantitative TLU and VHI at 6 months
Time frame: 6 months after surgery
Pearson correlation coefficient between postoperative quantitative TLU and loss or diminution of the intraoperative stimulation of the inferiors laryngeal nerves, expressed in microvolts, measured during the surgery.
Time frame: Between Day 1(the day after the surgery) and Day 15
Postoperative patient's satisfaction regarding TLU examination: six-point satisfaction questionnaire
Patient's satisfaction regarding TLU examination will be evaluated using a structured questionnaire (Strongly disagree; Slightly disagree; Neither agree nor disagree; Slightly agree; Strongly agree; Without opinion)
Time frame: Between Day 1 and Day 15
Postoperative patient's satisfaction regarding nasofibroscopic examination: six-point satisfaction questionnaire
Postoperative patient's satisfaction regarding nasofibroscopic examination will be evaluated using a structured six-point satisfaction six-point satisfaction questionnaire (Strongly disagree; Slightly disagree; Neither agree nor disagree; Slightly agree; Strongly agree; Without opinion)
Time frame: Between Day 1 and Day 15
Comparison between the costs associated with the nasofibroscopy of the one hand, and the TLU on the other hand.
The costs of nasofibroscopy on the one hand, and the TLU on the other, will be determined taking into account of the french social security system and its repayment as well as the time required to carry out the examinations, the purchase cost of the devices and its maintenance. The costs associated with the two examinations will be compared using the incremental cost-effectiveness ratio (ICER) and its 95% confidence interval
Time frame: 6 months
Diagnostic performance associated with the postoperative measurements obtained with the interactive software developed by the Mindray company of different points of the laryngeal anatomy for the diagnostic of postoperative recurrent nerve palsy (RNP).
The diagnostic performance of the postoperative measurement of asymmetry in vocal cord mobility obtained with the interactive software developed by the Mindray company will be evaluated by the area under the roc curve and its 95% confidence interval. The gold standard for diagnosis of postoperative RNP will be the nasofibroscopy performed between Day 1 and Day 15.
Time frame: Between Day 1 (the day after the surgery) and D15
Diagnostic performance comparison of the postoperative measure obtained with an interactive software developed by the Mindray company and with quantitative TLU measured by asymmetry in vocal cord mobility with our dedicated software of image analysis.
Comparison between the area under the roc curve of these two measurements, using Delong test.
Time frame: Between Day 1 (the day after the surgery) and Day 15
Concordance between the postoperative measure obtained with an interactive software developed by the Mindray company and with quantitative TLU (i.e. measured by asymmetry in vocal cord mobility obtained with our dedicated software of image analysis).
The concordance between these two measurements will be evaluated using a Bland and Altman plot
Time frame: Between Day 1 (the day after the surgery) and Day 15
Not enrolling at this site.
Not enrolling at this site.
Plan to share: No
Started Oct 2019 (actual). Primary completion is estimated for Jan 2024, 51 months after the start.
Of 20 interventional studies with no phase under Vocal Cord Paralysis, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 46. This study's planned 51 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assistance Publique - Hôpitaux de Paris →